CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 29,339			$ 174,422	$ 201,261
Marketable securities	264,184			146,902
Accounts receivable, net of allowance for expected credit losses	31,089			25,414
Inventory	32,969			26,123
Prepaid expenses and other current assets	9,378			9,234
Total current assets	366,960			382,095
Restricted cash	2,609			2,604
Property and equipment, net	17,662			17,926
Intangible assets, net	4,782			6,034
Operating lease right-of-use assets	16,876			18,251
Other non-current assets	2,137			1,657
Total assets	411,026			428,567
Current liabilities:
Accounts payable	6,378			5,048
Accrued compensation and benefits	9,860			14,170
Accrued expenses and other current liabilities	6,591			6,055
Deferred revenue	8,984			9,468
Operating lease liabilities	4,641			4,241
Total current liabilities	36,454			38,982
Deferred revenue, net of current portion	884			1,227
Operating lease liabilities, net of current portion	33,850			37,223
Other non-current liabilities	956			1,177
Total liabilities	72,144			78,609
Commitments and contingencies (Note 13)
Stockholders’ equity:
Common stock: $0.001 par value per share; Authorized: 120,000 shares; Issued and outstanding: 38,475 and 38,014 shares at September 30, 2024 and December 31, 2023, respectively	39			38
Additional paid-in capital	798,707			783,142
Accumulated other comprehensive loss	(1,411)			(1,672)
Accumulated deficit	(458,453)			(431,550)
Total stockholders’ equity	338,882	$ 340,778	$ 343,298	349,958	$ 352,787	$ 353,748	$ 355,194	$ 357,932
Total liabilities and stockholders’ equity	$ 411,026			$ 428,567